Regenxbio RGNX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$290.01M-49.6% | -$193.88M-9.0% | -$177.92M-1.3% | -$175.57M-11.3% | -$157.69M+30.6% | ||
| $15.52M-0.6% | $15.62M-1.0% | $15.77M-0.5% | $15.84M-0.9% | $15.99M-1.4% | ||
| $34.64M+0.2% | $34.56M-3.3% | $35.73M-2.4% | $36.62M-2.1% | $37.4M-2.8% | ||
| -$233.78M-88.6% | -$123.96M-20.0% | -$103.3M-17.5% | -$87.89M-4.6% | -$84.04M+51.5% | ||
| $2.63M+8.7% | $2.41M-19.1% | $2.99M+5.9% | $2.82M-2.9% | $2.9M+19.2% | ||
| —— | —— | —— | -$5.16M-104% | $135.27M+30.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$236.4M-87.1% | -$126.38M-18.9% | -$106.28M-17.2% | -$90.71M-4.3% | -$86.94M+50.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Regenxbio generate?
- Regenxbio (RGNX) generated -$233.8M in operating cash flow over the trailing twelve months.
- What is Regenxbio's free cash flow?
- After $2.6M of capital expenditures, Regenxbio's free cash flow was -$236.4M over the trailing twelve months, down 171.9% year over year.
- Where does Regenxbio's cash flow data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
